Blood glucose response after oral lactulose intake in type 2 diabetic individuals

BACKGROUND: Lactulose is approved for the symptomatic treatment of constipation, a gastrointestinal (GI) complication common in individuals with diabetes. Lactulose products contain carbohydrate impurities (e.g., lactose, fructose, galactose), which occur during the lactulose manufacturing process....

Descripción completa

Detalles Bibliográficos
Autores principales: Pieber, Thomas R, Svehlikova, Eva, Mursic, Ines, Esterl, Tamara, Wargenau, Manfred, Sartorius, Tina, Pauly, Lioba, Schwejda-Guettes, Susann, Neumann, Annalena, Faerber, Valentin, Stover, John Friedrich, Gaigg, Barbara, Kuchinka-Koch, Angelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192256/
https://www.ncbi.nlm.nih.gov/pubmed/34168736
http://dx.doi.org/10.4239/wjd.v12.i6.893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192256/
https://www.ncbi.nlm.nih.gov/pubmed/34168736
http://dx.doi.org/10.4239/wjd.v12.i6.893

Ejemplares similares